Syncom Formulations India Ltd (SYFI.BO)
SYFI.BO on Bombay Stock Exchange
110.70INR
24 May 2013
110.70INR
24 May 2013
Price Change (% chg)
Rs-3.35 (-2.94%)
Rs-3.35 (-2.94%)
Prev Close
Rs114.05
Rs114.05
Open
Rs109.05
Rs109.05
Day's High
Rs112.00
Rs112.00
Day's Low
Rs108.50
Rs108.50
Volume
8,837
8,837
Avg. Vol
21,122
21,122
52-wk High
Rs129.00
Rs129.00
52-wk Low
Rs33.50
Rs33.50
SYFI.BO
About
Syncom Formulations (India) Limited is an India-based pharmaceutica company. The Company manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments, Inhalers & Herbals.... (more)
No analyst recommendations are available for SYFI.BO.
Overall
| Beta: | 1.01 |
| Market Cap (Mil.): | Rs2,543.81 |
| Shares Outstanding (Mil.): | 22.30 |
| Dividend: | 0.60 |
| Yield (%): | 0.53 |
Financials
| SYFI.BO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 68.00 | 34.14 | 34.28 |
| EPS (TTM): | 1.68 | -- | -- |
| ROI: | -- | 19.49 | 18.85 |
| ROE: | -- | 20.26 | 19.72 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
